Richard Nowak, MD, MS
Associate Professor of Neurology; Director, Program in Clinical & Translational Neuromuscular Research; Director, Yale Myasthenia Gravis Clinic
Research & Publications
Biography
News
Locations
Research Summary
Dr. Nowak is focused on elucidating the immunopathologic mechanisms of myasthenia gravis, an autoimmune disorder targeting the neuromuscular junction in patients resulting in weakness. He is working toward identifying new drug targets as well as exploring the effectiveness of B cell directed therapies (e.g., rituximab).
Specialized Terms: Myasthenia Gravis; Guillian-Barre Syndrome (GBS); CIDP; Immune Therapies, Neuropathy; Charcot Marie Tooth Disease; ALS.
Extensive Research Description
https://medicine.yale.edu/neurology/divisions/neuromuscular/nmresearch.aspx
Research Interests
Amyotrophic Lateral Sclerosis; Charcot-Marie-Tooth Disease; Myasthenia Gravis; Neurology; Guillain-Barre Syndrome; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Clinical Trials
Conditions | Study Title |
---|---|
Diseases of the Nervous System | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis |
Diseases of the Nervous System | Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP |
Diseases of the Nervous System | Myasthenia Gravis Inebilizumab Trial (MINT) |
Diseases of the Musculoskeletal System | Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT) |
Diseases of the Nervous System | Immunologic Mechanisms in Neurological Diseases |
Diseases of the Musculoskeletal System; Diseases of the Nervous System | Registry of Patients With Generalized Myasthenia Gravis Who Have Ever Been Treated With C5 Inhibition Therapies |
Diseases of the Musculoskeletal System; Diseases of the Nervous System | Exploring Outcomes and Characteristics of Myasthenia Gravis 2 (EXPLORE-MG2) |